Navigation Links
Growth in Bioscience and Pharmaceutical R&D Drives the Market for Gene Expression Reagents, According to a New Trend Report Published by Global Industry Analysts, Inc.
Date:1/8/2014

San Jose, California (PRWEB) January 08, 2014

Follow us on LinkedIn – Gene expression refers to the process of unlocking the genetic code contained in the DNA. Understanding the functioning of genes remains critical towards identifying underlying causes of disease progression. Market for gene expression reagents has been benefiting from developments in biomedical gene expression profiling. As special chemicals developed for use in gene expression studies, gene expression reagents are currently witnessing strong demand in sync with the rise in gene expression tests. Growth in the market is also expected to benefit from the growing use of gene expression tests in diagnosis of thyroid cancer, colon cancer, multiple myeloma, uveal melanoma, and cardiovascular risk assessment.

The trend report titled “Gene Expression Reagents” announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the technology, its evolution, applications, future prospects, player market shares and corporate initiatives of key companies worldwide. The report also provides coverage on companies such as Affymetrix Inc., Agilent Technologies Inc., Epicentre® Biotechnologies, Eurogentec SA, Illumina Inc., Life Technologies Corporation, Mirus Bio LLC, Origene Technologies Inc., Roche Diagnostics, Sigma-Aldrich Co. LLC, and Thermo Fisher Scientific Inc., among others.

For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=146092.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/gene_expression_reagents/biomedical_market/prweb11471562.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Downsizing and the Need for Increased Selling Effectiveness Fuel Delta Points Growth
2. RSB Spine, LLC Announces 2011 Revenue Growth
3. ERT Launches New Website to Support Significant Commercial Growth
4. Phalanx Biotech Group Reports Robust Revenue Growth in 2011
5. Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
6. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
7. Carbon nanotubes can double growth of cell cultures important in industry
8. CannaBANK Acquires Rights to License PharmaSpheres Patented Growth System
9. First atomic-scale real-time movies of platinum nanocrystal growth in liquids
10. Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline
11. Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):